Breaking News

Cryoport, Cryo Store in Cryogenic Solutions Pact

Will use Cryoport's cryogenic logistics solutions to serve clients in Europe

By: Kristin Brooks

Managing Editor, Contract Pharma

Cryo Store BV, a European biostorage company, will utilize Cryoport’s cryogenic logistics solutions to serve the logistics needs of life sciences customers. Cryo Store provides storage and distribution services for temperature-controlled goods to pharma and biopharma companies in Europe.

Cryo Store will offer Cryoport’s cryogenic logistics solutions using its biostorage services, to address the risks and challenges of shipping in liquid nitrogen containers along with complex logistics systems. Cryoport’s cryogenic logistics solutions allow for the transportation of product without degradation of sample material for optimal sample usage to support high quality research. The full range of capabilities, including the Cryoportal logistics management platform, SmartPak II wireless condition monitoring system, and signature Cryoport Express dry vapor dewars.

Menno René Sappé, director, Cryo Store, said, “We chose to partner with Cryoport because of their cold chain logistics expertise and proven ability to manage the challenges of transporting valuable, temperature-sensitive biological materials. We immediately see the benefit of Cryoport’s specialized operating platform that employs industry-leading technology to ensure the timely and secure delivery of valuable samples. We are confident that Cryoport’s assistance in the cold chain logistics space will be an unparalleled asset to our biostorage business.”

Jerrell Shelton, chief executive officer of Cryoport, said, “Our partnership with Cryo Store marks yet another channel through which we are able to effectively support the cold chain market as the provider of the best-in-class cryogenic logistics solution.  Cryo Store’s biostorage services play an indispensable link in the global cold chain for a number of pharma and biotech companies’ biological material that is intended for clinical trials and patients throughout Europe.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters